Does ANTITHROMBIN III HUMAN Cause Thrombotic microangiopathy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Thrombotic microangiopathy have been filed in association with ANTITHROMBIN III HUMAN. This represents 5.4% of all adverse event reports for ANTITHROMBIN III HUMAN.
5
Reports of Thrombotic microangiopathy with ANTITHROMBIN III HUMAN
5.4%
of all ANTITHROMBIN III HUMAN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From ANTITHROMBIN III HUMAN?
Of the 5 reports, 5 (100.0%) required hospitalization, and 5 (100.0%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANTITHROMBIN III HUMAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ANTITHROMBIN III HUMAN Cause?
Drug ineffective (19)
Off label use (17)
Contraindicated product administered (11)
Prescribed overdose (11)
Foetal exposure during pregnancy (9)
Hepatic function abnormal (7)
Hyperglycaemia (7)
Premature baby (7)
Adenovirus infection (5)
Cholestasis (5)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)